Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

Results of the Surgical Treatment of Patients From Hepatobiliopancreatic Surgical Unit at the Complejo Hospitalario de Navarra

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04556019

Acronym

HPB

Enrollment

1000

Registered

2020-09-21

Start date

2019-01-03

Completion date

2029-01-31

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Diseases, Liver Diseases, Pancreas Disease, Surgical Procedure, Unspecified

Keywords

Hepatobiliopancreatic surgery

Brief summary

The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.

Interventions

PROCEDUREHepatobiliopancreatic surgery

Different surgical techniques tailored to each patient´s pathology

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

15 Years to 90 Years

Healthy volunteers

Inclusion criteria

* All patients operated by the HPB Surgical Unit in the last 10 years (retrospective) * All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).

Exclusion criteria

* Patients not eligible for surgery * Patients not interested in taking part in the study

Design outcomes

Primary

Measure	Time frame	Description
Rate of patient with post-surgical morbidity and mortality operated by the HPB Surgical Unit	90 days post-surgery	Morbidity and mortality outcomes are evaluated following the criteria and definitions from Claven-Dindo and ISGPS international classifications
Survival rate of patients operated by the HPB Surgical Unit	5-years post-surgery	These patients are operated due to tumoral cause
Disease-free survival rate of patients operated by the HPB Surgical Unit	5-years post-surgery	These patients are operated due to tumoral cause

Secondary

Measure	Time frame
Assessment of standardization of pre and post-surgical care	90 days
Assessment of the results from minimally invasive techniques in HPB surgery	90 days
Evaluation of the result of the multimodal treatment	90 days
Assessment of the oncological quality standards of patients operated by HPB Surgical Unit due to tumoral cause	5 years

Countries

Spain

Contacts

Primary ContactFrancisco Javier Herrera Cabezón, MD

javier.herrera.cabezon@cfnavarra.es0034 848422187

Backup ContactPablo Sánchez Acedo, MD

pablosanchez_84@hotmail.com0034 848422187

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026